Abstract
The contention that the new biotechnology can be directed to serve the interests of smallholders ignores the international institutional pressures created by the new technology. In contrast to the public character of the Green Revolution, the ‘bio‐revolution’ involves forces for the privatisation of research, and patent protection of biotechnological products. This article documents how the market, rather than the needs of smallholders, is determining the development of biotechnology, requiring Third World governments to shift support toward the creation of larger production units in order to attract funding for biotechnological R&D. This process is already visible in recent agricultural policy changes in Nigeria.
Notes
M. Phil Graduate of the Institute of Development Studies, University of Sussex, Falmer, Brighton BN1 9RE, UK. Thanks are due to Martin Greeley for inciting and commenting on this article, and to the Science Policy Research Unit for granting the author access to their library materials.